Drugs Made In America Acquisition Corp. (DMAAU) Retained Earnings (2024 - 2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Retained Earnings came in at -$7.3 million in Q4 2025, down 2496.1% YoY from $303203.4 in Q4 2024, and down 8.1% on a QoQ basis from -$6.7 million in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Retained Earnings (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 2 years of Retained Earnings data on file, last reported at -$7.3 million in Q4 2025.
- Quarterly Retained Earnings fell 2496.1% year-over-year to -$7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.3 million (down 2496.1% YoY) and the FY2025 annual result came in at -$7.3 million, down 2496.1% from the prior year.
- Retained Earnings retreated to -$7.3 million in Q4 2025, from -$6.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$279845.0 in Q4 2024 to a low of -$7.3 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.27 Mn |
| Sep 30, 2025 | -6.72 Mn |
| Jun 30, 2025 | -6.46 Mn |
| Mar 31, 2025 | -6.33 Mn |
| Dec 31, 2024 | -279,845.00 |